Simon Smith - Covalon Technologies Chief Ltd

COV Stock  CAD 3.74  0.09  2.47%   

Insider

Simon Smith is Chief Ltd of Covalon Technologies
Address 1660 Tech Avenue, Mississauga, ON, Canada, L4W 5S7
Phone905 568 8400
Webhttps://www.covalon.com

Covalon Technologies Management Efficiency

The company has return on total asset (ROA) of (0.0325) % which means that it has lost $0.0325 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0385) %, meaning that it generated substantial loss on money invested by shareholders. Covalon Technologies' management efficiency ratios could be used to measure how well Covalon Technologies manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.18 in 2024. Return On Capital Employed is likely to drop to -0.22 in 2024. At this time, Covalon Technologies' Non Current Assets Total are fairly stable compared to the past year. Other Current Assets is likely to climb to about 637.1 K in 2024, whereas Non Currrent Assets Other are likely to drop slightly above 115.6 K in 2024.
Covalon Technologies has accumulated 1.56 M in total debt with debt to equity ratio (D/E) of 2.49, implying the company greatly relies on financing operations through barrowing. Covalon Technologies has a current ratio of 0.62, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Covalon Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Covalon Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Covalon Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Covalon to invest in growth at high rates of return. When we think about Covalon Technologies' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Bill KingTECSYS Inc
N/A
John KarnesQuarterhill
62
Catherine SigmarTECSYS Inc
N/A
Cristina NunesWestaim Corp
N/A
Karen WoodfieldWestaim Corp
N/A
James FergusonPulse Seismic
N/A
Stephen WayWestaim Corp
75
Joseph SchenkWestaim Corp
N/A
Vito CalabrettaTECSYS Inc
N/A
Martin WulffTECSYS Inc
N/A
Nakul RandevWestaim Corp
N/A
Paul SunderlandQuarterhill
N/A
Catalin BadeaTECSYS Inc
N/A
Andrew ParolinQuarterhill
N/A
William AndrusWestaim Corp
74
Robert ColosinoTECSYS Inc
N/A
Rish MalhotraQuarterhill
N/A
CPA CFAWestaim Corp
52
Bret KiddQuarterhill
56
CA CMAWestaim Corp
63
Paul RichmanQuarterhill
81
Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, the United Kingdom, Europe, the Middle East, Asia, Latin America, and internationally. It serves hospitals, wound care centers, burn centers, extendedalternate care and acute care facilities, home health care agencies, and physicians offices. COVALON TECHNOLOGIES operates under Biotechnology classification in Exotistan and is traded on Commodity Exchange. Covalon Technologies (COV) is traded on TSX Venture Exchange in Canada and employs 28 people. Covalon Technologies is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Covalon Technologies Leadership Team

Elected by the shareholders, the Covalon Technologies' board of directors comprises two types of representatives: Covalon Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Covalon. The board's role is to monitor Covalon Technologies' management team and ensure that shareholders' interests are well served. Covalon Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Covalon Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Simon Smith, Chief Ltd
John Hands, Senior Director - Global Marketing
Greg Leszczynski, Vice Resources
Brent Ashton, CEO Director
Hamed Abbasian, Vice Development
Ian Brindle, Independent Director
Elaine Zhang, Vice Operations
Mark Doolittle, Senior Operations
Joseph Cordiano, Independent Director
Valerio DiTizio, Co-Founder and Chief Science Officer
Ronald Smith, Director
Gerry Arambula, President Ltd
Emily Hill, Executive CEO
Elinor Caplan, Director
Murray Miller, Independent Director
Kim Crooks, Vice President - Operations
Ron Hebert, VP Marketing
Gale Pollock, Director
Amir CFA, Executive Chairman
Jeffrey Mandel, Independent Director
Myrna Francis, Independent Director
Katie Martinovich, Interim Officer
Danny Brannagan, Chief Financial Officer
Brian Pedlar, President, Chief Executive Officer, Director
John Suk, Director
Ronald Hebert, Senior Marketing
Jason Gorel, Interim Officer
Abe Schwartz, Chairman of The Board, Advisor and Member of Audit Committee

Covalon Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Covalon Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Covalon Stock Analysis

When running Covalon Technologies' price analysis, check to measure Covalon Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Covalon Technologies is operating at the current time. Most of Covalon Technologies' value examination focuses on studying past and present price action to predict the probability of Covalon Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Covalon Technologies' price. Additionally, you may evaluate how the addition of Covalon Technologies to your portfolios can decrease your overall portfolio volatility.